Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Cathy LORD |
Documents disponibles écrits par cet auteur (1)
Faire une suggestion Affiner la recherche
Measuring social communication behaviors as a treatment endpoint in individuals with autism spectrum disorder / Evdokia ANAGNOSTOU in Autism, 19-5 (July 2015)
[article]
Titre : Measuring social communication behaviors as a treatment endpoint in individuals with autism spectrum disorder Type de document : Texte imprimé et/ou numérique Auteurs : Evdokia ANAGNOSTOU, Auteur ; Nancy JONES, Auteur ; Marisela HUERTA, Auteur ; Alycia K. HALLADAY, Auteur ; Paul WANG, Auteur ; Lawrence SCAHILL, Auteur ; Joseph P. HORRIGAN, Auteur ; Connie KASARI, Auteur ; Cathy LORD, Auteur ; Dennis W. CHOI, Auteur ; Katherine SULLIVAN, Auteur ; Geraldine DAWSON, Auteur Article en page(s) : p.622-636 Langues : Anglais (eng) Mots-clés : autism spectrum disorders behavioral measurement outcome measures social cognition and social behavior Index. décimale : PER Périodiques Résumé : Social communication impairments are a core deficit in autism spectrum disorder. Social communication deficit is also an early indicator of autism spectrum disorder and a factor in long-term outcomes. Thus, this symptom domain represents a critical treatment target. Identifying reliable and valid outcome measures for social communication across a range of treatment approaches is essential. Autism Speaks engaged a panel of experts to evaluate the readiness of available measures of social communication for use as outcome measures in clinical trials. The panel held monthly conference calls and two face-to-face meetings over 14?months. Key criteria used to evaluate measures included the relevance to the clinical target, coverage of the symptom domain, and psychometric properties (validity and reliability, as well as evidence of sensitivity to change). In all, 38 measures were evaluated and 6 measures were considered appropriate for use, with some limitations. This report discusses the relative strengths and weaknesses of existing social communication measures for use in clinical trials and identifies specific areas in need of further development. En ligne : http://dx.doi.org/10.1177/1362361314542955 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=261
in Autism > 19-5 (July 2015) . - p.622-636[article] Measuring social communication behaviors as a treatment endpoint in individuals with autism spectrum disorder [Texte imprimé et/ou numérique] / Evdokia ANAGNOSTOU, Auteur ; Nancy JONES, Auteur ; Marisela HUERTA, Auteur ; Alycia K. HALLADAY, Auteur ; Paul WANG, Auteur ; Lawrence SCAHILL, Auteur ; Joseph P. HORRIGAN, Auteur ; Connie KASARI, Auteur ; Cathy LORD, Auteur ; Dennis W. CHOI, Auteur ; Katherine SULLIVAN, Auteur ; Geraldine DAWSON, Auteur . - p.622-636.
Langues : Anglais (eng)
in Autism > 19-5 (July 2015) . - p.622-636
Mots-clés : autism spectrum disorders behavioral measurement outcome measures social cognition and social behavior Index. décimale : PER Périodiques Résumé : Social communication impairments are a core deficit in autism spectrum disorder. Social communication deficit is also an early indicator of autism spectrum disorder and a factor in long-term outcomes. Thus, this symptom domain represents a critical treatment target. Identifying reliable and valid outcome measures for social communication across a range of treatment approaches is essential. Autism Speaks engaged a panel of experts to evaluate the readiness of available measures of social communication for use as outcome measures in clinical trials. The panel held monthly conference calls and two face-to-face meetings over 14?months. Key criteria used to evaluate measures included the relevance to the clinical target, coverage of the symptom domain, and psychometric properties (validity and reliability, as well as evidence of sensitivity to change). In all, 38 measures were evaluated and 6 measures were considered appropriate for use, with some limitations. This report discusses the relative strengths and weaknesses of existing social communication measures for use in clinical trials and identifies specific areas in need of further development. En ligne : http://dx.doi.org/10.1177/1362361314542955 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=261